HomeClinical ResearchCurrent Clinical Trails A Phase 1b/2, Open-Label, Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Castrate Resistant Prostate Cancer
Arc 6
Condition: Metastatic Castrate Resistant Prostate Cancer | Last Updated: | Status: